Kiromic BioPharma Inc (KRBP)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Pietro Bersani
Employees:
60
7707 FANNIN ST., SUITE 140, HOUSTON, TX 77054
832-968-4888
Date | Ratio |
---|---|
2023-03-13 | 1:30 |
Kiromic BioPharma focuses on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin. It has license agreements with Mercer University; CGA 369 Intellectual Holdings, Inc.; and Longwood University.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|